Clinical trials
Lymphoma, T-Cell trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2013 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Terminated | 6 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Lymphoma Academic Research Organisation | 3 |
| Celgene | 2 |
| Hospices Civils de Lyon | 2 |
| miRagen Therapeutics, Inc. | 2 |
| Acrotech Biopharma Inc. | 1 |
| BeiGene | 1 |
| French Innovative Leukemia Organisation | 1 |
| Innate Pharma | 1 |
| Janssen Research & Development, LLC | 1 |
| Mundipharma Research Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 24 |
| Lymphoma | 10 |
| Lymphoma, Non-Hodgkin | 9 |
| Lymphoma, T-Cell, Cutaneous | 7 |
| Lymphoma, T-Cell, Peripheral | 6 |
| Recurrence | 6 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoproliferative Disorders | 4 |
| Mycosis Fungoides | 4 |
| Immune System Diseases | 3 |
Trials
Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.